Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105981 | 12610598 | 1 | I | 20160727 | 20160801 | 20160801 | EXP | CA-OTSUKA-2016_018470 | OTSUKA | 0.00 | Y | 0.00000 | 20160801 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126105981 | 12610598 | 1 | PS | BUSULFEX | BUSULFAN | 1 | Intravenous (not otherwise specified) | 12.8 MG/KG, UNK (SOLUTION INTRAVENOUS) | 20955 | 12.8 | MG/KG | INJECTION | |||||||
| 126105981 | 12610598 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | UNK (SOLUTION INTRAVENOUS) | 0 | INJECTION | |||||||||
| 126105981 | 12610598 | 3 | SS | CISPLATIN. | CISPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 5 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | UNK (SOLUTION INTRAVENOUS) | 0 | INJECTION | |||||||||
| 126105981 | 12610598 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 7 | SS | FILGRASTIM | FILGRASTIM | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 8 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Unknown | 250 MG/M2, UNK | 0 | 250 | MG/M**2 | ||||||||
| 126105981 | 12610598 | 9 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 11 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK (SOLUTION INTRAVENOUS) | 0 | INJECTION | |||||||||
| 126105981 | 12610598 | 12 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126105981 | 12610598 | 13 | SS | ZEVALIN | IBRITUMOMAB TIUXETAN | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126105981 | 12610598 | 1 | B-cell lymphoma |
| 126105981 | 12610598 | 2 | B-cell lymphoma |
| 126105981 | 12610598 | 3 | B-cell lymphoma |
| 126105981 | 12610598 | 4 | B-cell lymphoma |
| 126105981 | 12610598 | 5 | B-cell lymphoma |
| 126105981 | 12610598 | 6 | B-cell lymphoma |
| 126105981 | 12610598 | 7 | B-cell lymphoma |
| 126105981 | 12610598 | 8 | B-cell lymphoma |
| 126105981 | 12610598 | 9 | B-cell lymphoma |
| 126105981 | 12610598 | 10 | B-cell lymphoma |
| 126105981 | 12610598 | 11 | B-cell lymphoma |
| 126105981 | 12610598 | 12 | B-cell lymphoma |
| 126105981 | 12610598 | 13 | B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126105981 | 12610598 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126105981 | 12610598 | Meningitis tuberculous | |
| 126105981 | 12610598 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |